ALPS Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$797K Buy
36,199
+7,375
+26% +$148K ﹤0.01% 744
2026
Q2
$591K Buy
28,824
+3,402
+13% +$57.7K ﹤0.01% 904
2026
Q1
$404K Buy
25,422
+36
+0.1% +$781 ﹤0.01% 950
2025
Q4
$667K Buy
25,386
+10,847
+75% +$281K ﹤0.01% 663
2025
Q3
$329K Sell
14,539
-1,873
-11% -$38.6K ﹤0.01% 946
2025
Q2
$326K Sell
16,412
-6,340
-28% -$124K ﹤0.01% 907
2025
Q1
$385K Sell
22,752
-1,980
-8% -$33.7K ﹤0.01% 634
2024
Q4
$457K Buy
24,732
+1,790
+8% +$34.9K ﹤0.01% 635
2024
Q3
$499K Sell
22,942
-420
-2% -$9.39K ﹤0.01% 610
2024
Q2
$458K Buy
+23,362
New +$488K ﹤0.01% 593
2022
Q1
– Sell
-4,253
Closed -$428K – 879
2021
Q4
$428K Buy
4,253
+51
+1% +$4.48K ﹤0.01% 593
2021
Q3
$378K Buy
4,202
+1,101
+36% +$100K ﹤0.01% 622
2021
Q2
$286K Hold
3,101
– – ﹤0.01% 860
2021
Q1
$300K Buy
+3,101
New +$320K ﹤0.01% 822

Other funds holding FLGT

ALPS Advisors's FLGT Position: Q3 2026 in Review

ALPS Advisors increased its Fulgent Genetics (FLGT) stake by 26% in Q3 2026, buying an estimated $148K and bringing the position to 36,199 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

ALPS Advisors first reported a position in FLGT in Q1 2021 and has held it in 14 quarters since. 47 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • ALPS Advisors held 36,199 shares of Fulgent Genetics worth $797K as of Q3 2026.
  • ALPS Advisors bought 7,375 Fulgent Genetics shares in Q3 2026, an estimated $148K.
  • Fulgent Genetics made up ﹤0.01% of ALPS Advisors's portfolio in Q3 2026, its #744 holding.
  • ALPS Advisors first reported a position in Fulgent Genetics in Q1 2021 and has held it in 14 quarters since.
  • 47 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.